Memory Loss in Alzheimer’s and Dopamine Have a Strong Link, New Study Finds

Scientists have identified a new factor that may explain why memory declines in Alzheimer’s disease, pointing to a disruption in dopamine, a chemical in the brain involved in learning and memory.

The research, conducted by a team at the University of California, Irvine, shows that reduced dopamine activity in a key memory-related region of the brain can directly impair the ability to form new memories.

Memory plays a central role in everyday life, helping people connect experiences, such as linking sounds, places, and events. While scientists have long known that memory formation depends on areas within the brain’s medial temporal lobe, the exact biological changes that lead to memory loss in Alzheimer’s have not been fully understood.

In this study, researchers focused on the entorhinal cortex, a region that plays a major role in processing and passing memory-related information to other parts of the brain. They found that dopamine levels in this area were significantly reduced in a model of Alzheimer’s disease, and brain cells were less responsive to information that should normally be learned.

The team then tested whether restoring dopamine levels could improve memory function. By increasing dopamine activity, they were able to recover memory formation. Similar improvements were observed when using Levodopa, a drug commonly prescribed for Parkinson’s disease.

Researchers said they did not initially expect dopamine to play such a major role in Alzheimer’s. However, their findings suggest that dopamine dysfunction may be a key contributor to memory problems.

Alzheimer’s disease affects millions of people worldwide, and current treatments remain limited. Most therapies focus on targeting harmful proteins in the brain, but these approaches often do not restore memory once damage has occurred.

The new findings provide a broader understanding of how memory systems break down in Alzheimer’s. By focusing on the underlying brain processes, scientists believe this approach could lead to new treatment strategies to slow cognitive decline.